Table 3.
Clinical information when ART initiated (N = 2046) | IPT exposed N (%) |
IPT Non-exposed N (%) |
N (%) | Chi-square P value |
---|---|---|---|---|
WHO stage of HIV/AIDS | ||||
Stage 1 | 151(16.02) | 138(12.5) | 289(14.1) | 0.000 |
Stage 2 | 367(39) | 294(26.6) | 661(32.3) | |
Stage 3 | 394 (41.8) | 551(49.9) | 945(46.2) | |
Stage 4 | 30 (3.18) | 121(11.0) | 151(7.4) | |
CD4cells count/μl(mean = 151.2, SD = 84.9) | ||||
≤200 | 537 (37.9) | 1020(92.4) | 1557(76.1) | 0.000 |
>200 | 263 (27.9) | 226(20.5) | 489(23.9) | |
Weight in Kg (mean = 53.2, SD = 9.5) | ||||
<50 | 241(25.6) | 506(45.8) | 747(36.5) | 0.011 |
50–59 | 479(44.2) | 366(33.1) | 845(41.3) | |
60–69 | 164 (17.4) | 164(14.9) | 328(16.0) | |
>69 | 58 (6.2) | 68(6.2) | 126(6.2) | |
TB screened | ||||
Yes | 942(100) | 1100(99.6) | 2042(99.8) | 0.64 |
No | 0 | 4(0.4) | 4(0.2) | |
CPT adherence | ||||
Good | 791(84) | 1096(99.3) | 2032(99.6) | 0.046 |
Fair | 3(.32) | 6(0.5) | 9(0.3) | |
Poor | 3(.32) | 2(0.2) | 5(0.2) | |
ART adherence | ||||
Good | 937(99.5) | 1100(99.6) | 2037(99.6) | 0.124 |
Fair | 5(0.53) | 2(0.2) | 7(0.3) | |
Poor | 0 | 2(0.2) | 2(0.1) | |
OIs after ART initiated | ||||
None | 937(99.5) | 1052(95.3) | 1989(97.21) | 0.000 |
Fungal | 3(.32) | 20(1.8) | 23(1.12) | |
Viral | 0 | 12(1.0) | 12(0.5) | |
Bacterial | 0 | 12(1.0) | 14(0.7) | |
Bacterial & fungal | 0 | 4(0.4) | 4(0.2) | |
Othersa | 0 | 4(0.4) | 4(0.2) |
aProtozoal, viral & bacterial & fungal & viral infections